1986
DOI: 10.1016/0165-6147(86)90330-5
|View full text |Cite
|
Sign up to set email alerts
|

Antimycotic sterol biosynthesis inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
17
0

Year Published

1989
1989
2017
2017

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 24 publications
(17 citation statements)
references
References 18 publications
0
17
0
Order By: Relevance
“…It possesses a broad spectrum of activity in vitro against dermatophytes, molds, yeasts, dimorphic fungi, and some Gram-positive bacteria [1]. It has a double mechanism of action as it works by preventing the 14-α-demethylation of 24-methylenedihydrolanosterol, consequently preventing the formation of the cellular membrane by inhibiting the production of ergosterol, and also causes direct damage to the membrane [2]. It also shows an antiinflammatory effect on erythema caused by histamine [3,4].…”
Section: карактеризација на инклузиони комплекси меѓу бифоназол и разmentioning
confidence: 99%
“…It possesses a broad spectrum of activity in vitro against dermatophytes, molds, yeasts, dimorphic fungi, and some Gram-positive bacteria [1]. It has a double mechanism of action as it works by preventing the 14-α-demethylation of 24-methylenedihydrolanosterol, consequently preventing the formation of the cellular membrane by inhibiting the production of ergosterol, and also causes direct damage to the membrane [2]. It also shows an antiinflammatory effect on erythema caused by histamine [3,4].…”
Section: карактеризација на инклузиони комплекси меѓу бифоназол и разmentioning
confidence: 99%
“…In so doing the drawbacks arising from optically impure reagents or different rates of formation of the diastereoisomers are avoided. Because patients with acquired immunodeficiency syndrome or undergoing anti-cancer chemotherapy or organ transplants are susceptible to bacterial and fungal diseases, new classes of antifungal drugs have been developed since 1970 and in particular, novel antifungal agents, imidazole and triazole derivatives, some of which contain stereogenic centres [7,8]. In some cases the individual isomers of these compounds differ in their pharmacological activity.…”
Section: Introductionmentioning
confidence: 99%
“…This combination is thought to combine the well-documented antifungal activity of bifonazole [4,5] with the known keratoplastic effect of urea [6]. In numerous clinical trials, the efficacy of this ointment has been demonstrated [3].…”
Section: Introductionmentioning
confidence: 99%